Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
Authors
Keywords
-
Journal
LEUKEMIA
Volume 29, Issue 10, Pages 2062-2068
Publisher
Springer Nature
Online
2015-07-31
DOI
10.1038/leu.2015.212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic activity of multiple common -chain cytokine inhibition in acute and chronic GVHD
- (2014) A.-K. Hechinger et al. BLOOD
- Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans
- (2014) R. Flynn et al. BLOOD
- Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
- (2014) S. Spoerl et al. BLOOD
- Current issues in chronic graft-versus-host disease
- (2014) G. Socie et al. BLOOD
- Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis
- (2014) S Mielke et al. BONE MARROW TRANSPLANTATION
- Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage
- (2014) Lukas Schwab et al. NATURE MEDICINE
- Extracorporeal photopheresis in acute and chronic graft-versus-host disease
- (2014) Hildegard T. Greinix et al. TRANSFUSION AND APHERESIS SCIENCE
- Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
- (2013) Joel Kremer et al. ANNALS OF INTERNAL MEDICINE
- Current Practice in Diagnosis and Treatment of Acute Graft-versus-Host Disease: Results from a Survey among German-Austrian-Swiss Hematopoietic Stem Cell Transplant Centers
- (2013) Daniel Wolff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
- (2013) A. Heine et al. BLOOD
- Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
- (2013) Ming J. Poi et al. CLINICAL PHARMACOKINETICS
- First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
- (2012) Paul J. Martin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: Results of treatment with the COBE Spectra System
- (2012) A H Hautmann et al. BONE MARROW TRANSPLANTATION
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- The best endpoint for acute GVHD treatment trials
- (2010) M. L. MacMillan et al. BLOOD
- SMAD3 prevents graft-versus-host disease by restraining Th1 differentiation and granulocyte-mediated tissue damage
- (2010) M. Giroux et al. BLOOD
- Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective
- (2010) N Schub et al. BONE MARROW TRANSPLANTATION
- Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD
- (2010) S Thiant et al. BONE MARROW TRANSPLANTATION
- Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD
- (2010) A Rager et al. BONE MARROW TRANSPLANTATION
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- (2010) Chie Onishi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study
- (2009) Carmen Martínez et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Successful Treatment of Severe Acute Intestinal Graft-versus-Host Resistant to Systemic and Topical Steroids with Alemtuzumab
- (2009) Marc Schnitzler et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation
- (2009) C. Bucher et al. BLOOD
- Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
- (2009) D Hoda et al. BONE MARROW TRANSPLANTATION
- Therapy with mycophenolate mofetil for refractory acute and chronic GVHD
- (2009) T Furlong et al. BONE MARROW TRANSPLANTATION
- Rapamycin for Refractory Acute Graft-Versus-Host Disease
- (2009) David Ghez et al. TRANSPLANTATION
- Antithymocyte globulin therapy for steroid-resistant acute graft versus host disease
- (2008) Mónica Ballesteros et al. AMERICAN JOURNAL OF HEMATOLOGY
- Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD
- (2008) P Perfetti et al. BONE MARROW TRANSPLANTATION
- Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host Disease
- (2008) Robert M. Dean et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More